Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages

  Panda, Harekrushna ^a   Chuang, Tsai Der ^a   Luo, Xiaoping ^a   Chegini, Nasser ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; MICRORNA; MICRORNA 181A; MICRORNA 98; PROGESTERONE; PROGESTERONE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CCNE1 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOCHROME P450 AROMATASE GENE; DEAD BOX POLYPEPTIDE 3 X LINKED GENE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; FOLLICULAR PHASE; GENE; GENE EXPRESSION; GENE REPRESSION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUTEAL PHASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGESTERONE RECEPTOR GENE; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1 GENE; TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 3 GENE;

ADULT; AGED; AROMATASE; CARCINOMA, ENDOMETRIOID; CELL TRANSFORMATION, NEOPLASTIC; DEAD-BOX RNA HELICASES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICRORNAS; MIDDLE AGED; PRECANCEROUS CONDITIONS; RECEPTORS, PROGESTERONE; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84863565271     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1018     Document Type: Article

References (55)

1. Bartel DP 2009 MicroRNA: target recognition and regulatory functions. Cell 136:215-233
2. Djuranovic S, Nahvi A, Green R 2011 A parsimonious model for gene regulation by miRNA. Science 331:550-553
3. Fabian MR, Sonenberg N, Filipowicz W 2010 Regulation of mRNA translation and stability by microRNA. Annu Rev Biochem 79:351-379
4. Almeida MI, Reis RM, Calin GA 2011 MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res 717:1-8
5. Hagen JW, Lai EC 2008 microRNA control of cell-cell signaling during development and disease. Cell Cycle 7:2327-2332
6. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, Kamath S, Chen DT, Dressman H, Lancaster JM 2008 MicroRNA and their target messenger RNA associated with endometrial carcinogenesis. Gynecol Oncol 110:206-215
7. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Bénès V, Roché H, Dalenc F, Auboeuf D, Millevoi S, Vagner S 2009 Widespread estrogen-dependent repression of microRNA involved in breast tumor cell growth. Cancer Res 69:8332-8340
8. Creighton CJ, Benham AL, Zhu H, Khan MF, Reid JG, Nagaraja AK, Fountain MD, Dziadek O, Han D, Ma L, Kim J, Hawkins SM, Anderson ML, Matzuk MM, Gunaratne PH 2010 Discovery of novel microRNA in female reproductive tract using next generation sequencing. PLoS ONE 5:e9637
9. Hawkins SM, Buchold GM, Matzuk MM 2011 The roles of small RNA pathways in reproductive medicine. Mol Endocrinol 25:1257-1279
10. Lam EW, Shah K, Brosens JJ 2012 The diversity of sex steroid action: the role of micro-RNA and FOXO transcription factors in cycling endometrium and cancer. J Endocrinol 212:13-25
11. Ohlsson Teague EM, Print CG, Hull ML 2010 The role of microRNA in endometriosis and associated reproductive conditions. Hum Reprod Update 16:142-165
12. Pan Q, Chegini N 2008 MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med 26:479-493
13. Bulun SE, Simpson ER 2008 Aromatase expression in women's cancers. Adv Exp Med Biol 630:112-132
14. Critchley HO, Saunders PT 2009 Hormone receptor dynamics in a receptive human endometrium. Reprod Sci 16:191-199
15. Di Cristofano A, Ellenson LH 2007 Endometrial carcinoma. Annu Rev Pathol 2:57-85 (Pubitemid 46448060)
16. Eliassen AH, Hankinson SE 2008 Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 630:148-165
17. Geisler JP, Buller E, Manahan KJ 2008 Estrogen receptor α and βexpression in a case matched series of serous and endometrioid adenocarcinomas of the ovary. Eur J Gynaecol Oncol 29:126-128 (Pubitemid 351498393)
18. Gründker C, Günthert AR, Emons G 2008 Hormonal heterogeneity of endometrial cancer. Adv Exp Med Biol 630:166-188
19. Hawkins SM, Matzuk MM 2008 The menstrual cycle: basic biology. Ann NY Acad Sci 1135:10-18 (Pubitemid 351862132)
20. Kim JJ, Chapman-Davis E 2010 Role of progesterone in endometrial cancer. Semin Reprod Med 28:81-90
21. Mylonas I, Jeschke U, Shabani N, Kuhn C, Kunze S, Dian D, Friedl C, Kupka MS, Friese K 2007 Steroid receptors ERα, ERβ, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 22:169-176 (Pubitemid 46117102)
22. Bonéy-Montoya J, Ziegler YS, Curtis CD, Montoya JA, Nardulli AM 2010 Long-range transcriptional control of progesterone receptor gene expression. Mol Endocrinol 24:346-358
23. Cheskis BJ, Greger JG, Nagpal S, Freedman LP 2007 Signaling by estrogens. J Cell Physiol 213:610-617 (Pubitemid 350058252)
24. Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R, Strissel PL 2009 Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci 66:2405-2426
25. McCormack O, Harrison M, Kerin MJ, McCann A 2007 Role of the progesterone receptor (PR) and the PR isoforms in breast cancer. Crit Rev Oncog 13:283-301 (Pubitemid 351655044)
26. Zhao C, Dahlman-Wright K, Gustafsson JA 2008 Estrogen receptor β: an overview and update. Nucl Recept Signal 6:e003
27. Hanekamp EE, Gielen SC, De Ruiter PE, Chadha-Ajwani S, Huikeshoven FJ, Burger CW, Grootegoed JA, Blok LJ 2005 Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins. J Soc Gynecol Investig 12:278-284 (Pubitemid 40615099)
28. Leslie KK, Stein MP, Kumar NS, Dai D, Stephens J, Wandinger-Ness A, Glueck DH 2005 Progesterone receptor isoform identification and subcellular localization in endometrial cancer. Gynecol Oncol 96:32-41 (Pubitemid 39612414)
29. Ryan AJ, Susil B, Jobling TW, Oehler MK 2005 Endometrial cancer. Cell Tissue Res 322:53-61 (Pubitemid 41677655)
30. Schindler AE 2009 Progestogen deficiency and endometrial cancer risk. Maturitas 62:334-337
31. Sorosky JI 2008 Endometrial cancer. Obstet Gynecol 111:436-447 (Pubitemid 351653438)
32. Wendler A, Keller D, Albrecht C, Peluso JJ, Wehling M 2011 Involvement of let-7/miR-98 microRNA in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells. Oncol Rep 25:273-279
33. Ahmed IS, Rohe HJ, Twist KE, Mattingly MN, Craven RJ 2010 Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule. J Pharmacol Exp Ther 333:564-573
34. Peluso JJ 2011 Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer. Steroids 76:903-909
35. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood 3rd W, Becker KG, Morin PJ 2008 MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3:e2436
36. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K 2009 MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113: 396-402
37. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K 2010 TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29: 1787-1797
38. Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H 2011 Distinct expressions of microRNA that directly target estrogen receptor α in human breast cancer. Breast Cancer Res Treat 130:331-339
39. Arnett-Mansfield RL, DeFazio A, Mote PA, Clarke CL 2004 Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J Clin Endocrinol Metab 89:1429-1442 (Pubitemid 38368448)
40. Dai D, Wolf DM, Litman ES, White MJ, Leslie KK 2002 Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 62:881-886 (Pubitemid 34126968)
41. Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, Husen B, Thole H, Dunselman G, Groothuis P 2007 Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 22:3148-3158 (Pubitemid 351696776)
42. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE 2000 Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85:2897-2902 (Pubitemid 32269170)
43. Hanekamp EE, Kühne LM, Grootegoed JA, Burger CW, Blok LJ 2004 Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice. Endocr Relat Cancer 11:831-841 (Pubitemid 40065555)
44. Cuesta R, Martínez-Sánchez A, Gebauer F 2009 miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells. Mol Cell Biol 29:2841-2851
45. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A 2009 2009 miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 7:1234-1243
46. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ 2007 High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6:5
47. Hu G, Zhou R, Liu J, Gong AY, Eischeid AN, Dittman JW, Chen XM2009 MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J Immunol 183:1617-1624
48. Huang S, Wu S, Ding J, Lin J, Wei L, Gu J, He X 2010 MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res 38:7211-7218
49. Liu Y, Chen Q, Song Y, Lai L, Wang J, Yu H, Cao X, Wang Q 2011 MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett 585:1963-1968
50. Ouyang YB, Lu Y, Yue S, Giffard RG 2012 miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 12:213-219
51. Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E, Yue S, O'Sullivan B, Liu FF 2010 Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 1:e85
52. Wang S, Tang Y, Cui H, Zhao X, Luo X, Pan W, Huang X, Shen N 2011 Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun 12:149-154
53. Flötotto T, Niederacher D, Hohmann D, Heimerzheim T, Dall P, Djahansouzi S, Bender HG, HansteinB2004 Molecular mechanism of estrogen receptor (ER)α-specific, estradiol-dependent expression of the progesterone receptor (PR) B-isoform. J Steroid Biochem Mol Biol 88:131-142 (Pubitemid 38488853)
54. Fujiyama-Nakamura S, Yamagata K, Kato S 2011 Hormonal repression of miRNA biosynthesis through a nuclear steroid hormone receptor. Adv Exp Med Biol 700:43-55
55. Nothnick WB, Healy C, Hong X 2010 Steroidal regulation of uterine miRNA is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1. Endocrine 37:265-273